NCT00689039View on ClinicalTrials.gov

Study of an Extended Release (ER) Tablet, Single and Repeated Dosing

PHASE1CompletedINTERVENTIONAL

Enrollment

94

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Healthy

Interventions

DRUG

AZD1305

ER tablet, administered as single and repeated doses.

DRUG

Placebo

Tablet, administered as single and repeated doses.

Trial Locations (1)

Unknown

Research Site, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY